A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response

Leukemia. 2009 Jun;23(6):1199-201. doi: 10.1038/leu.2009.43. Epub 2009 Mar 5.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Benzamides
  • Fusion Proteins, bcr-abl / analysis
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Middle Aged
  • Pilot Projects
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Remission Induction

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Granulocyte Colony-Stimulating Factor
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl